Showing 2 posts of 2 posts found.
Breast cancer patients in England and Wales now have access to another treatment option, as NICE announces its recommendation of …
Eli Lilly and patients with breast cancer patients in the UK have been dealt a blow as NICE confirmed that …
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection
Coriolis Pharma appoints Teun van der Heide as CEO